Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Eli Lilly Stock Tumbles as Q3 Sales Profits Fall Well Short of Estimates

October 31, 2024
Eli Lilly and Company, a leading pharmaceutical company, experienced a significant decline in its stock value as its sales and profits in the third quarter fell well below market estimates. The company's flagship product, Zepbound, failed to meet sales targets, contributing to the disappointing financial results. As a result, investors reacted by selling off their shares, causing a sharp drop in the company's stock price. This latest setback raises concerns about Eli Lilly's ability to maintain its market position and financial performance in a highly competitive industry. To gain insights into the future movement of Eli Lilly's stock, it is advisable to consult professionals from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

ABBVNovember 14, 2024AbbVie Faces Setback as Schizophrenia Drug Trials Fall Short  ~2 min.

Pharmaceutical giant AbbVie Inc. (ABBV) experienced a significant drop in stock prices today, following disappointing results from their latest schizophrenia drug trials....

LLYNovember 3, 2024Eli Lilly stock tumbles on Q3 miss; Zepbound sales fall short  ~1 min.

Eli Lilly and Company, a leading global pharmaceutical company, experienced a significant decline in its stock value as it reported lower-than-expected sales and a miss on its Q3 earnings....

NVOMarch 20, 2025Investor Disappointment Causes Novo Nordisk AS NVO Stocks to Trade Lower  ~2 min.

Novo Nordisk AS, a leading pharmaceutical company, has experienced a decline in stock prices due to investor disappointment over its new drug in obesity....

LLYNovember 2, 2024Eli Lilly stock tumbles on Q3 miss  ~1 min.

Eli Lilly and Company, a global pharmaceutical giant, experienced a significant drop in its stock value following the release of its Q3 earnings report....

VRTXJanuary 14, 2025Vertex Pharmaceuticals Inc. Faces Setbacks in Clinical Trials, Resulting in Stock Slide  ~2 min.

Vertex Pharmaceuticals Inc....